Re-shaping a regulatory agency fit for the future

07-05-2013

The first details of the planned reorganisation of the European Medicines Agency (EMA) have been announced. Rooted firmly in the Agency’s overall public and animal health mission, the changes reflect a renewed focus on three key elements: how to better support the scientific work of the EMA ...

more

30-04-2013

Following the recent recommendation by the Pharmacovigilance Risk Assessment Committee (PRAC), the Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) has endorsed by majority the PRAC recommendation to suspend the marketing authorisations of ...

more

18-04-2013

The European Medicines Agency has published its 2012 annual report. The report highlights the main trends recently observed in the Agency’s activities. For the past few years, the Agency has received a stable number of initial marketing authorisation applications (MAAs) for human medicines, ...

more

EMA to give advice to European Commission on public and animal health impact

17-04-2013

The European Medicines Agency (EMA) will provide advice on the impact on public health and animal health of the use of antibiotics in animals. The request was made by the European Commission as part of its ‘Action Plan against the rising threats from Antimicrobial Resistance ...

more

GIZ, BASF and Cargill partnership reaches 2,500 smallholder coconut growers

06-02-2013

A program to develop a certified coconut oil supply chain to enhance sustainability and improve the livelihoods of 2,500 coconut growers in the Philippines has been launched. It is a result of a partnership between the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, BASF ...

more

04-02-2013

Boston Scientific Corporation released results of a survey of more than 1,000 chronic pain sufferers across Europe that suggest millions of patients there continue to suffer on a daily basis even after trying several treatment options. “The Painful Truth Survey: The State of Pain Management ...

more

30-10-2012

A number of European Union (EU) Member States have halted the use, as a precautionary measure, of some anti-influenza vaccines manufactured by Novartis Vaccines, because of a suspected quality defect. The Italian Medicines Agency (AIFA) was first informed of the suspected quality defect by ...

more

15-10-2012

EuropaBio warmly welcomes the European Commission’s new proposal on industrial policy for growth and economic recovery. Launched by Vice President Tajani, following extensive consultation and analysis, the Communication builds on the work of the Lead Market Initiative (LMI) and highlights ...

more

20-08-2012

The Renewable Fuel Standard provides the fundamental foundation driving private investment in America’s advanced biofuels industry. The Biotechnology Industry Organization (BIO) responded to formal requests by Gov. Bev Perdue (D-N.C.) and Gov. Mike Beebe (D-Ark.) that the Environmental ...

more

Better protection of public health through strengthened EU system for medicines safety

04-07-2012

The European Medicines Agency welcomes the start of new European Union (EU) legislation on pharmacovigilance. This new piece of legislation aims to promote and protect public health by strengthening the existing Europe-wide system for monitoring the safety and benefit-risk balance of ...

more